Ajou University repository

Obesity Exacerbates Coxsackievirus Infection via Lipid-Induced Mitochondrial Reactive Oxygen Species Generationoa mark
  • Kim, Seong Ryeol ;
  • Song, Jae Hyoung ;
  • Ahn, Jae Hee ;
  • Jeong, Myeong Seon ;
  • Yang, Yoon Mee ;
  • Cho, Jaewon ;
  • Jeong, Jae Hyeon ;
  • Cha, Younggil ;
  • Kim, Kil Nam ;
  • Kim, Hong Pyo ;
  • Chang, Sun Young ;
  • Ko, Hyun Jeong
Citations

SCOPUS

5

Citation Export

Publication Year
2022-04-01
Publisher
Korean Association of Immunologists
Citation
Immune Network, Vol.22
Keyword
Coxsackievirus B3Lipid metabolismMitochondriaMitoquinoneObesityReactive oxygen species
All Science Classification Codes (ASJC)
Immunology and AllergyImmunologyInfectious Diseases
Abstract
Coxsackievirus B3 (CVB3) infection causes acute pancreatitis and myocarditis. However, its pathophysiological mechanism is unclear. Here, we investigated how lipid metabolism is associated with exacerbation of CVB3 pathology using high-fat diet (HFD)-induced obese mice. Mice were intraperitoneally inoculated with 1×106 pfu/mouse of CVB3 after being fed a control or HFD to induce obesity. Mice were treated with mitoquinone (MitoQ) to reduce the level of mitochondrial ROS (mtROS). In obese mice, lipotoxicity of white adipose tissue-induced inflammation caused increased replication of CVB3 and mortality. The coxsackievirus adenovirus receptor increased under obese conditions, facilitating CVB3 replication in vitro. However, lipid-treated cells with receptor-specific inhibitors did not reduce CVB3 replication. In addition, lipid treatment increased mitochondria-derived vesicle formation and the number of multivesicular bodies. Alternatively, we found that inhibition of lipid-induced mtROS decreased viral replication. Notably, HFD-fed mice were more susceptible to CVB3-induced mortality in association with increased levels of CVB3 replication in adipose tissue, which was ameliorated by administration of the mtROS inhibitor, MitoQ. These results suggest that mtROS inhibitors can be used as potential treatments for CVB3 infection.
Language
eng
URI
https://dspace.ajou.ac.kr/dev/handle/2018.oak/32704
DOI
https://doi.org/10.4110/in.2022.22.e19
Fulltext

Type
Article
Funding
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (grant No. NRF-2020R1A2B5B02001552, NRF-2020R1A5A8019180 and NRF-2019R1I1A1A01060238) and the Korea Basic Science Institute, Republic of Korea (grant No. C140360). This research was supported by Korea Basic Science Institute (National research Facilities and Equipment Center) grant funded by the Ministry of Education (grant No. 2020R1A6C101A195).
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Kim, Hong Pyo Image
Kim, Hong Pyo김홍표
Division of Pharmacy Sciences
Read More

Total Views & Downloads

File Download

  • There are no files associated with this item.